# OnCo record sp-002 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/sp-002/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "sp-002" ;
  schema:name "SP-002"@en ;
  schema:alternateName "ASN-002"@en ;
  schema:description "SP-002 is an experimental gene therapy: replication-deficient adenovirus serotype 5 vector, injected into the tumour from Stamford Pharmaceuticals, in phase 2 trials for basal cell carcinoma and cutaneous squamous cell carcinoma."@en ;
  schema:url <https://onco.cc/drugs/sp-002/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://stamfordpharmaceuticals.com/>, <https://stamfordpharmaceuticals.com/>, <https://clinicaltrials.gov/study/NCT06344052>, <https://clinicaltrials.gov/search?intr=SP-002> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Gene therapy: replication-deficient adenovirus serotype 5 vector, injected into the tumour" ;
  onco:cancers <https://onco.cc/cancers/basal-cell-carcinoma/> ;
  onco:companies <https://onco.cc/companies/stamford-pharmaceuticals/> ;
  onco:trials <https://onco.cc/trials/nct06344052/>, <https://onco.cc/trials/nct04416516/> .